NNOX Nano X Imaging

Nanox to Report Second Quarter 2025 Financial Results on August 12, 2025

Nanox to Report Second Quarter 2025 Financial Results on August 12, 2025

PETACH TIKVA, Israel, Aug. 01, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended June 30, 2025, before market open on Tuesday, August 12, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.

Interested parties may register for the conference call using the following link: . The live webcast of the conference call may be accessed by using the following link.

The link will also be posted in the Investor Relations section of the Nanox website at . 

About Nanox

Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by bringing a full solution of affordable medical imaging technologies based on advanced AI and proprietary digital X-ray source.

Nanox's vision encompasses expanding the reach of Nanox technology both within and beyond hospital settings, providing a seamless end-to-end solution from scan to diagnosis, leveraging AI for more accurate diagnostics and maintaining a clinically driven approach. The Nanox ecosystem includes Nanox.ARC – a multi-source digital tomosynthesis system that is cost-effective and user-friendly; Nanox.AI LTD, a subsidiary of Nanox Imaging, with an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic diseases; Nanox.CLOUD – a cloud-based software platform that manages data collected by Nanox devices, and provides users with tools for in-depth imaging analysis; Nanox.MARKETPLACE – a proprietary decentralized marketplace through Nanox’s subsidiary, USARAD Holdings Inc., that provides remote access to radiology and cardiology experts, and a comprehensive teleradiology services platform. By improving early detection and treatment, Nanox aims to enhance better health outcomes worldwide. For more information, please visit .

Contacts

Investor Contact

Mike Cavanaugh

ICR Healthcare

 

Media Contact

ICR Healthcare

 



EN
01/08/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nano X Imaging

 PRESS RELEASE

Nanox Expands in Latin America with Exclusive Nanox.ARC Distribution A...

Nanox Expands in Latin America with Exclusive Nanox.ARC Distribution Agreement in Argentina Collaboration with Intec SRL drives commercial expansion of 3D medical imaging across a high-growth private healthcare market PETACH TIKVA, Israel, Feb. 19, 2026 (GLOBE NEWSWIRE) -- (“Nanox”, Nasdaq: NNOX), a leader in innovative medical imaging technology, today announced a distribution agreement with Intec SRL, an Argentina-based medical device distributor with more than 35 years of experience delivering advanced imaging technologies to healthcare providers nationwide. The is a multi-source d...

 PRESS RELEASE

Nanox to Showcase Nanox.ARC Live in Europe for First Time and Present ...

Nanox to Showcase Nanox.ARC Live in Europe for First Time and Present New AI Capabilities at ECR 2026 Live demonstrations of the Nanox.ARC will feature at the ECR booth #425 in Hall X4Oral presentation by Dr. Nogah Shabshin to present data on potential role of digital tomosynthesis in lung cancer screeningOral presentation by Dr. Orit Wimpfheimer to explore how Nanox AI transforms routine CT scans into tools for early detection of cardiovascular disease, osteoporosis and fatty liver diseasePoster presentations to highlight new clinical data from ADOPT study featuring AI bone solution PETAC...

 PRESS RELEASE

Nanox Receives FDA 510(k) Clearance for TAP2D New Image Enhancement Ca...

Nanox Receives FDA 510(k) Clearance for TAP2D New Image Enhancement Capability for Nanox.ARC and Nanox.ARC X Systems This clearance enables the next phase of development aimed ultimately at removing the adjunct use in the US The newly cleared capability provides radiologists with a 2D image generated directly from the tomosynthesis scan, enabling both 3D and 2D views from a single scan, without exposing the patient to any additional radiation PETACH TIKVA, Israel – February 3 – (“Nanox” or the “Company”) today announced that the United States Food and Drug Administration (FDA) has gran...

 PRESS RELEASE

Nanox Expands in Europe with New Nanox.ARC Distribution Engagement in ...

Nanox Expands in Europe with New Nanox.ARC Distribution Engagement in Serbia, Montenegro, and Bosnia and Herzegovina Collaboration with Adriamed drives commercial expansion and strengthens Nanox’s regional leadership Engagement supports continued growth across multiple European markets, following recent collaborations in Greece, Romania, and PETACH TIKVA, ISRAEL – January 14, 2026 – (“Nanox”, Nasdaq: NNOX), a leader in innovative medical imaging technology, today announced a new collaboration with (“Adriamed”), a Belgrade-based medical device distributor serving healthcare providers a...

 PRESS RELEASE

Nanox Engages with Althea France to Accelerate European Commercializat...

Nanox Engages with Althea France to Accelerate European Commercialization of Nanox.ARC System Althea France, part of one of Europe's largest independent medical technology services providers, to distribute CE-marked Nanox.ARC system across French healthcare sector Partnership represents Nanox's fourth European distribution agreement following recent collaborations in Greece, Romania and Czech Republic PETACH TIKVA, ISRAEL – November 25, 2025 (GLOBE NEWSWIRE) -- (“Nanox” or the “Company”, Nasdaq: NNOX), an innovative medical imaging technology company, today announced a distribution colla...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch